These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15368078)

  • 1. Stem-cell transplantation for the treatment of advanced solid tumors.
    Nieto Y; Jones RB; Shpall EJ
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):31-56. PubMed ID: 15368078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem-cell transplantation for solid tumors in adults.
    Nieto Y; Shpall EJ
    Hematol Oncol Clin North Am; 1999 Oct; 13(5):939-68, vi. PubMed ID: 10553256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
    McGuire WP
    Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
    Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
    Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy for the treatment of breast and ovarian cancer.
    Cagnoni PJ; Shpall EJ
    Curr Opin Oncol; 1997 Mar; 9(2):122-5. PubMed ID: 9161788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
    Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
    Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors.
    Mandanas RA; Saez RA; Epstein RB; Confer DL; Selby GB
    Bone Marrow Transplant; 1998 Mar; 21(6):569-76. PubMed ID: 9543060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].
    Mukaiyama T; Okamoto R; Sasaki T
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1731-40. PubMed ID: 7574803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.
    Ben-Yosef R; Or R; Naparstek E; Kapelushnik J; Samuels S; Slavin S; Nagler A
    Am J Clin Oncol; 1997 Aug; 20(4):419-23. PubMed ID: 9256903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
    Weaver CH; Birch R; Schwartzberg LS; West WH
    Cancer Treat Res; 1995; 76():59-85. PubMed ID: 7577345
    [No Abstract]   [Full Text] [Related]  

  • 12. [High-dose chemotherapy with stem cell support for solid tumors in adults].
    Rodenhuis S; de Vries EG
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
    Cheng YC; Ueno NT
    Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
    Maraninchi D; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.
    McCauley DL
    Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease in solid tumor malignancies: a review.
    Ross AA
    J Hematother; 1998 Feb; 7(1):9-18. PubMed ID: 9507377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
    Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
    Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy of breast cancer.
    Crown J; Raptis G; Hamilton N; Hudis C; Vahclat L; Fennelly D; Norton L
    Can J Oncol; 1995 Dec; 5 Suppl 1():80-2. PubMed ID: 8853530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.